COVID-19 Outbreak-Global Nuclear Medicine & Radio Pharmaceuticals Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

August 2020 | 105 pages | ID: C5CEE53A94EDEN
Maia Research

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question

The Nuclear Medicine & Radio Pharmaceuticals market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Nuclear Medicine & Radio Pharmaceuticals industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Nuclear Medicine & Radio Pharmaceuticals market can be split based on product types, major applications, and important countries as follows:

Key players in the global Nuclear Medicine & Radio Pharmaceuticals market covered in Chapter 12:
Carestream
Shimadzu
Hitachi
Esaote
GE Healthcare
Toshiba
Biosensors International Group, Ltd.
Philips Healthcare
TriFoil Imaging
Siemens Healthcare

In Chapter 4 and 14.1, on the basis of types, the Nuclear Medicine & Radio Pharmaceuticals market from 2015 to 2025 is primarily split into:
Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes.

In Chapter 5 and 14.2, on the basis of applications, the Nuclear Medicine & Radio Pharmaceuticals market from 2015 to 2025 covers:
Diagnostic Applications: SPECT, PET.
Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 NUCLEAR MEDICINE & RADIO PHARMACEUTICALS INTRODUCTION AND MARKET OVERVIEW

1.1 Objectives of the Study
1.2 Overview of Nuclear Medicine & Radio Pharmaceuticals
1.3 Scope of The Study
  1.3.1 Key Market Segments
  1.3.2 Players Covered
  1.3.3 COVID-19's impact on the Nuclear Medicine & Radio Pharmaceuticals industry
1.4 Methodology of The Study
1.5 Research Data Source

2 EXECUTIVE SUMMARY

2.1 Market Overview
  2.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size, 2015 – 2020
  2.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Size by Type, 2015 – 2020
  2.1.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Size by Application, 2015 – 2020
  2.1.4 Global Nuclear Medicine & Radio Pharmaceuticals Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
  2.2.1 Global COVID-19 Status and Economic Overview
  2.2.2 Influence of COVID-19 Outbreak on Nuclear Medicine & Radio Pharmaceuticals Industry Development

3 INDUSTRY CHAIN ANALYSIS

3.1 Upstream Raw Material Suppliers of Nuclear Medicine & Radio Pharmaceuticals Analysis
3.2 Major Players of Nuclear Medicine & Radio Pharmaceuticals
3.3 Nuclear Medicine & Radio Pharmaceuticals Manufacturing Cost Structure Analysis
  3.3.1 Production Process Analysis
  3.3.2 Manufacturing Cost Structure of Nuclear Medicine & Radio Pharmaceuticals
  3.3.3 Labor Cost of Nuclear Medicine & Radio Pharmaceuticals
3.4 Market Distributors of Nuclear Medicine & Radio Pharmaceuticals
3.5 Major Downstream Buyers of Nuclear Medicine & Radio Pharmaceuticals Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally

4 GLOBAL NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET, BY TYPE

4.1 Global Nuclear Medicine & Radio Pharmaceuticals Value and Market Share by Type (2015-2020)
4.2 Global Nuclear Medicine & Radio Pharmaceuticals Production and Market Share by Type (2015-2020)
4.3 Global Nuclear Medicine & Radio Pharmaceuticals Value and Growth Rate by Type (2015-2020)
  4.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Value and Growth Rate of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
  4.3.2 Global Nuclear Medicine & Radio Pharmaceuticals Value and Growth Rate of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes.
4.4 Global Nuclear Medicine & Radio Pharmaceuticals Price Analysis by Type (2015-2020)

5 NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET, BY APPLICATION

5.1 Downstream Market Overview
5.2 Global Nuclear Medicine & Radio Pharmaceuticals Consumption and Market Share by Application (2015-2020)
5.3 Global Nuclear Medicine & Radio Pharmaceuticals Consumption and Growth Rate by Application (2015-2020)
  5.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Consumption and Growth Rate of Diagnostic Applications: SPECT, PET. (2015-2020)
  5.3.2 Global Nuclear Medicine & Radio Pharmaceuticals Consumption and Growth Rate of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. (2015-2020)

6 GLOBAL NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS BY REGIONS

6.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Regions
  6.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales by Regions (2015-2020)
  6.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Regions (2015-2020)
6.2 North America Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
6.3 Europe Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
6.6 South America Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)

7 NORTH AMERICA NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS BY COUNTRIES

7.1 The Influence of COVID-19 on North America Market
7.2 North America Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
  7.2.1 North America Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
  7.2.2 North America Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2015-2020)
7.3 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
7.4 Canada Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
7.5 Mexico Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)

8 EUROPE NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS BY COUNTRIES

8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
  8.2.1 Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
  8.2.2 Europe Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2015-2020)
8.3 Germany Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
8.4 UK Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
8.5 France Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
8.6 Italy Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
8.7 Spain Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
8.8 Russia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)

9 ASIA PACIFIC NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS BY COUNTRIES

9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
  9.2.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
  9.2.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2015-2020)
9.3 China Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
9.4 Japan Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
9.5 South Korea Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
9.6 India Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
9.8 Australia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)

10 MIDDLE EAST AND AFRICA NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS BY COUNTRIES

10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
  10.2.1 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
  10.2.2 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2015-2020)
10.3 Saudi Arabia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
10.4 UAE Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
10.5 Egypt Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
10.6 Nigeria Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
10.7 South Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)

11 SOUTH AMERICA NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET ANALYSIS BY COUNTRIES

11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
  11.2.1 South America Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
  11.2.2 South America Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2015-2020)
11.3 Brazil Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
11.4 Argentina Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
11.5 Columbia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
11.6 Chile Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)

12 COMPETITIVE LANDSCAPE

12.1 Carestream
  12.1.1 Carestream Basic Information
  12.1.2 Nuclear Medicine & Radio Pharmaceuticals Product Introduction
  12.1.3 Carestream Production, Value, Price, Gross Margin 2015-2020
12.2 Shimadzu
  12.2.1 Shimadzu Basic Information
  12.2.2 Nuclear Medicine & Radio Pharmaceuticals Product Introduction
  12.2.3 Shimadzu Production, Value, Price, Gross Margin 2015-2020
12.3 Hitachi
  12.3.1 Hitachi Basic Information
  12.3.2 Nuclear Medicine & Radio Pharmaceuticals Product Introduction
  12.3.3 Hitachi Production, Value, Price, Gross Margin 2015-2020
12.4 Esaote
  12.4.1 Esaote Basic Information
  12.4.2 Nuclear Medicine & Radio Pharmaceuticals Product Introduction
  12.4.3 Esaote Production, Value, Price, Gross Margin 2015-2020
12.5 GE Healthcare
  12.5.1 GE Healthcare Basic Information
  12.5.2 Nuclear Medicine & Radio Pharmaceuticals Product Introduction
  12.5.3 GE Healthcare Production, Value, Price, Gross Margin 2015-2020
12.6 Toshiba
  12.6.1 Toshiba Basic Information
  12.6.2 Nuclear Medicine & Radio Pharmaceuticals Product Introduction
  12.6.3 Toshiba Production, Value, Price, Gross Margin 2015-2020
12.7 Biosensors International Group, Ltd.
  12.7.1 Biosensors International Group, Ltd. Basic Information
  12.7.2 Nuclear Medicine & Radio Pharmaceuticals Product Introduction
  12.7.3 Biosensors International Group, Ltd. Production, Value, Price, Gross Margin 2015-2020
12.8 Philips Healthcare
  12.8.1 Philips Healthcare Basic Information
  12.8.2 Nuclear Medicine & Radio Pharmaceuticals Product Introduction
  12.8.3 Philips Healthcare Production, Value, Price, Gross Margin 2015-2020
12.9 TriFoil Imaging
  12.9.1 TriFoil Imaging Basic Information
  12.9.2 Nuclear Medicine & Radio Pharmaceuticals Product Introduction
  12.9.3 TriFoil Imaging Production, Value, Price, Gross Margin 2015-2020
12.10 Siemens Healthcare
  12.10.1 Siemens Healthcare Basic Information
  12.10.2 Nuclear Medicine & Radio Pharmaceuticals Product Introduction
  12.10.3 Siemens Healthcare Production, Value, Price, Gross Margin 2015-2020

13 INDUSTRY OUTLOOK

13.1 Market Driver Analysis
  13.1.2 Market Restraints Analysis
  13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release

14 GLOBAL NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET FORECAST

14.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Value & Volume Forecast, by Type (2020-2025)
  14.1.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Market Value and Volume Forecast (2020-2025)
  14.1.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. Market Value and Volume Forecast (2020-2025)
14.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Value & Volume Forecast, by Application (2020-2025)
  14.2.1 Diagnostic Applications: SPECT, PET. Market Value and Volume Forecast (2020-2025)
  14.2.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Market Value and Volume Forecast (2020-2025)
14.3 Nuclear Medicine & Radio Pharmaceuticals Market Analysis and Forecast by Region
  14.3.1 North America Market Value and Consumption Forecast (2020-2025)
  14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
  14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
  14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
  14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 NEW PROJECT FEASIBILITY ANALYSIS

15.1 Industry Barriers and New Entrants SWOT Analysis
  15.1.1 Porter’s Five Forces Analysis
  15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
LIST OF TABLES AND FIGURES

Figure Product Picture of Nuclear Medicine & Radio Pharmaceuticals
Table Product Specification of Nuclear Medicine & Radio Pharmaceuticals
Table Nuclear Medicine & Radio Pharmaceuticals Key Market Segments
Table Key Players Nuclear Medicine & Radio Pharmaceuticals Covered
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Size, 2015 – 2025
Table Different Types of Nuclear Medicine & Radio Pharmaceuticals
Figure Global Nuclear Medicine & Radio Pharmaceuticals Value ($) Segment by Type from 2015-2020
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Share by Types in 2019
Table Different Applications of Nuclear Medicine & Radio Pharmaceuticals
Figure Global Nuclear Medicine & Radio Pharmaceuticals Value ($) Segment by Applications from 2015-2020
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Share by Applications in 2019
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Share by Regions in 2019
Figure North America Nuclear Medicine & Radio Pharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Nuclear Medicine & Radio Pharmaceuticals
Table Upstream Raw Material Suppliers of Nuclear Medicine & Radio Pharmaceuticals with Contact Information
Table Major Players Headquarters, and Service Area of Nuclear Medicine & Radio Pharmaceuticals
Figure Major Players Production Value Market Share of Nuclear Medicine & Radio Pharmaceuticals in 2019
Table Major Players Nuclear Medicine & Radio Pharmaceuticals Product Types in 2019
Figure Production Process of Nuclear Medicine & Radio Pharmaceuticals
Figure Manufacturing Cost Structure of Nuclear Medicine & Radio Pharmaceuticals
Figure Channel Status of Nuclear Medicine & Radio Pharmaceuticals
Table Major Distributors of Nuclear Medicine & Radio Pharmaceuticals with Contact Information
Table Major Downstream Buyers of Nuclear Medicine & Radio Pharmaceuticals with Contact Information
Table Global Nuclear Medicine & Radio Pharmaceuticals Value ($) by Type (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Value Share by Type (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Value Share by Type (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production by Type (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production Share by Type (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Share by Type (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Value ($) and Growth Rate of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Value ($) and Growth Rate of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption by Application (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Application (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Application (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption and Growth Rate of Diagnostic Applications: SPECT, PET. (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption and Growth Rate of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Regions (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Regions (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue (M USD) by Regions (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions (2015-2020)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions in 2015
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions in 2019
Figure North America Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Nuclear Medicine & Radio Pharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table North America Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
Table North America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2015-2020)
Table North America Nuclear Medicine & Radio Pharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table North America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure Canada Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure Mexico Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2015-2020)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Germany Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure UK Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure France Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure Italy Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure Spain Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure Russia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2015-2020)
Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure China Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure India Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure Australia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure Middle East Nuclear Medicine & Radio Pharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table Middle East Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure UAE Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure Egypt Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure Nigeria Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure South Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Revenue (M USD) and Growth (2015-2020)
Table South America Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2015-2020)
Table South America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2015-2020)
Table South America Nuclear Medicine & Radio Pharmaceuticals Revenue (M USD) by Countries (2015-2020)
Table South America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Brazil Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure Argentina Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure Columbia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure Chile Nuclear Medicine & Radio Pharmaceuticals Sales and Growth (2015-2020)
Figure Top 3 Market Share of Nuclear Medicine & Radio Pharmaceuticals Companies in 2019
Figure Top 6 Market Share of Nuclear Medicine & Radio Pharmaceuticals Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Carestream Profile
Table Carestream Product Introduction
Figure Carestream Production and Growth Rate
Figure Carestream Value ($) Market Share 2015-2020
Table Shimadzu Profile
Table Shimadzu Product Introduction
Figure Shimadzu Production and Growth Rate
Figure Shimadzu Value ($) Market Share 2015-2020
Table Hitachi Profile
Table Hitachi Product Introduction
Figure Hitachi Production and Growth Rate
Figure Hitachi Value ($) Market Share 2015-2020
Table Esaote Profile
Table Esaote Product Introduction
Figure Esaote Production and Growth Rate
Figure Esaote Value ($) Market Share 2015-2020
Table GE Healthcare Profile
Table GE Healthcare Product Introduction
Figure GE Healthcare Production and Growth Rate
Figure GE Healthcare Value ($) Market Share 2015-2020
Table Toshiba Profile
Table Toshiba Product Introduction
Figure Toshiba Production and Growth Rate
Figure Toshiba Value ($) Market Share 2015-2020
Table Biosensors International Group, Ltd. Profile
Table Biosensors International Group, Ltd. Product Introduction
Figure Biosensors International Group, Ltd. Production and Growth Rate
Figure Biosensors International Group, Ltd. Value ($) Market Share 2015-2020
Table Philips Healthcare Profile
Table Philips Healthcare Product Introduction
Figure Philips Healthcare Production and Growth Rate
Figure Philips Healthcare Value ($) Market Share 2015-2020
Table TriFoil Imaging Profile
Table TriFoil Imaging Product Introduction
Figure TriFoil Imaging Production and Growth Rate
Figure TriFoil Imaging Value ($) Market Share 2015-2020
Table Siemens Healthcare Profile
Table Siemens Healthcare Product Introduction
Figure Siemens Healthcare Production and Growth Rate
Figure Siemens Healthcare Value ($) Market Share 2015-2020
Table Market Driving Factors of Nuclear Medicine & Radio Pharmaceuticals
Table Merger, Acquisition and New Investment
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Value ($) Forecast, by Type
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Volume Forecast, by Type
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Value ($) and Growth Rate Forecast of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Volume ($) and Growth Rate Forecast of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Value ($) and Growth Rate Forecast of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. (2020-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Volume ($) and Growth Rate Forecast of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Diagnostic Applications: SPECT, PET. (2020-2025)
Figure Market Volume and Growth Rate Forecast of Diagnostic Applications: SPECT, PET. (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. (2020-2025)
Figure Market Volume and Growth Rate Forecast of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery


More Publications